- Home
- / Achelios Therapeutics
Achelios Therapeutics
Total Funding
$3.2 M
Achelios Therapeutics Summary
Company Summary
- Overview
- Achelios Therapeutics is a biopharmaceutical development company specializing in the reformulation of non-steroidal anti-inflammatory drug (NSAID) molecules. It offers TOPOFEN, a product that pairs a transdermal drug delivery technology system, and TOPOGEL, a non-steroidal anti-inflammatory molecule.
- Type
- Private
- Status
- Active
- Founded
- 2012
- HQ
- Durham, NC, US | view all locations
- Website
- http://achelios.com/
- Cybersecurity rating
Table of Contents
Key People
John Fort, Chief Medical Officer and Vice President of Clinical Operations
James L. Yeager, Vice President Formulation Development
Mike S Fox, Chief Business and Commercial Officer
LocationsView all
1 location detected
Durham, NC HQ
United States
4364 S Alston Ave #300
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026